comparison of different practical indices for assessing carbohydrate quality among carbohydrate-rich processed products in the US
GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide act on appetite regulation, satiety signaling, and gastric emptying
In my clinical experience, many patients who plateau on semaglutide see renewed progress after transitioning to tirzepatide, although individual results vary and treatment decisions should always be guided by a medical provider
From a purely mechanistic perspective, there are no known direct negative interactions
Stacking / Combinations The blend is itself a stack the entire point is that it already combines the two peptides addressing the two main repair bottlenecks (supply via BPC-157, cell mobility via TB-500)
Researchers should view the combination as mechanistically plausible rather than clinically proven